Madison Avenue Partners »

Hess shares owned by Madison Avenue Partners

Quarter-by-quarter ownership of Hess (HES) shares owned by Madison Avenue Partners from 13F filings

Historical chart of Madison Avenue Partners investment in Hess

Tip: Access up to 7 years of quarterly data

All positions including Hess held by Madison Avenue Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hess by Madison Avenue Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $43M 300k 144.16

More positions owned by Madison Avenue Partners

Sharkninja Com Shs (SN)
Graham Hldgs Com Cl B (GHC)
Theravance Biopharma (TBPH)
Stagwell Com Cl A (STGW)
Integra Lifesciences Hlds C Com New (IART)
G-III Apparel (GIII)
Hess (HES)
Vestis Corporation Com Shs (VSTS)
Mirati Therapeutics
Orion Office Reit Inc-w/i (ONL)
Ovid Therapeutics (OVID)
Franklin Street Properties (FSP)
2seventy Bio Common Stock (TSVT)
Merrimack Pharmaceuticals Com New (MACK)
Gossamer Bio (GOSS)

View all positions for Madison Avenue Partners

Top funds holding Hess

Vanguard Group
PRIMECAP Management Company
Pentwater Capital Management
T. Rowe Price Associates
Balyasny Asset Management
Fayez Sarofim & Co
Barrow, Hanley, Mewhinney & Strauss
Millennium Management
Massachusetts Financial Services
Barclays
Bank of America Corporation
Ubs Global Asset Management Americas
Susquehanna International
Legal & General Group
Amundi

View all funds holding Hess